CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tilray Inc Company Snapshot
Tilray Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tilray Inc with three other companies in this sector in UNITED STATES : Amicus Therapeutics, Inc (2019 sales of $182.24 million of which 100% was Biopharmaceutical), Xencor Inc ($156.70 million of which 72% was Licensing), and Retrophin Inc ($175.34 million of which 100% was Innovative therapies).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tilray Inc
  Stock Performance Chart for Tilray Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 6.73
(Figures in U.S. Dollars)
1 Week 21.0%   13 Weeks 40.5%  
4 Weeks -5.5%   52 Weeks -71.6%  
 
Tilray Inc Key Data:
  Ticker: TLRY Country: Canada
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 166,979,000
(Year Ending Jan 2020).		 Employees: 1,646
  Currency: U.S. Dollars Market Cap: 691,717,644
  Fiscal Yr Ends: December Shares Outstanding: 102,781,225
  Share Type: Class 2 Common Closely Held Shares: 39,943,996
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.